Next Generation Vaccine Biomarkers workshop October 30–31, 2014 – Ottawa, Canada

References

• Virot P. 10 Facts on Immunization (World Health Organization). 2012
   Google Scholar
• Krishnan L, Twine S, Gerdts V, Barreto L, Richards JC. Canadian Adjuvant Initiative Workshop, March 26-27, 2013–Ottawa, Canada. Hum Vaccin Immunother 2014; 10:519-26; PMID:24192752; http://dx.doi.org/10.4161/hv.26972
   PubMed Web of Science ®Google Scholar
• Qiu X, Fernando L, Alimonti JB, Melito PL, Feldmann F, Dick D, Stroher U, Feldmann H, Jones SM. Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. Plos One 2009; 4:e5547; PMID:19440245; http://dx.doi.org/10.1371/journal.pone.0005547
   PubMed Web of Science ®Google Scholar
• Qiu X, Fernando L, Melito PL, Audet J, Feldmann H, Kobinger G, Alimonti JB, Jones SM. Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection. PLoS Negl Trop Dis 2012; 6:e1575; PMID:22448295; http://dx.doi.org/10.1371/journal.pntd.0001575
   PubMed Web of Science ®Google Scholar
• Qiu X, Audet J, Wong G, Pillet S, Bello A, Cabral T, Strong JE, Plummer F, Corbett CR, Alimonti JB, et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med 2012; 4:138ra81; PMID:22700957; http://dx.doi.org/10.1126/scitranslmed.3003876
   PubMed Web of Science ®Google Scholar
• Katz R. Biomarkers and surrogate markers: an FDA perspective. NeuroRx 2004; 1:189-95; PMID:15717019; http://dx.doi.org/10.1602/neurorx.1.2.189
   PubMedGoogle Scholar
• Chun S, Li C, Van Domselaar G, Wang J, Farnsworth A, Cui X, Rode H, Cyr TD, He R, Li X. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine 2008; 26:6068-76; PMID:19007587; http://dx.doi.org/10.1016/j.vaccine.2008.09.015
   PubMed Web of Science ®Google Scholar
• Li C, Jaentschke B, Song Y, Wang J, Cyr TD, Van Domselaar G, He R, Li X. A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide. Nature Protocols 2010; 5:14-9; PMID:20010723; http://dx.doi.org/10.1038/nprot.2009.200
   PubMed Web of Science ®Google Scholar
• Ryden P, Twine S, Shen H, Harris G, Chen W, Sjostedt A, Conlan W. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria. Mol Immunol 2013; 54:58-67; PMID:23201853; http://dx.doi.org/10.1016/j.molimm.2012.10.043
   PubMed Web of Science ®Google Scholar
• Cowley SC, Elkins KL. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors. J Exp Med 2003; 198:379-89; PMID:12885873; http://dx.doi.org/10.1084/jem.20030687
   PubMed Web of Science ®Google Scholar
• Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W. BALB/c mice, but not C57BL/6 mice immunized with a DeltaclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses. Vaccine 2012; 30:3634-45; PMID:22484348; http://dx.doi.org/10.1016/j.vaccine.2012.03.036
   PubMed Web of Science ®Google Scholar
• Whitfield DM, Eichler EE, Sprott GD. Synthesis of archaeal glycolipid adjuvants-what is the optimum number of sugars? Carbohydrate Res 2008; 343:2349-60; http://dx.doi.org/10.1016/j.carres.2008.06.021
   PubMed Web of Science ®Google Scholar
• Sprott GD, Dicaire CJ, Cote JP, Whitfield DM. Adjuvant potential of archaeal synthetic glycolipid mimetics critically depends on the glyco head group structure. Glycobiol 2008; 18:559-65http://dx.doi.org/10.1093/glycob/cwn038
   PubMed Web of Science ®Google Scholar
• Krishnan L, Gurnani K, Dicaire CJ, van Faassen H, Zafer A, Kirschning CJ, Sad S, Sprott GD. Rapid clonal expansion and prolonged maintenance of memory CD8+ T cells of the effector (CD44highCD62Llow) and central (CD44highCD62Lhigh) phenotype by an archaeosome adjuvant independent of TLR2. J Immunol 2007; 178:2396-406; PMID:17277146; http://dx.doi.org/10.4049/jimmunol.178.4.2396
   PubMed Web of Science ®Google Scholar
• Gerdts V, Babiuk LA, van Drunen Littel-van den H, Griebel PJ. Fetal immunization by a DNA vaccine delivered into the oral cavity. Nature Med 2000; 6:929-32; PMID:10932233; http://dx.doi.org/10.1038/78699
   PubMed Web of Science ®Google Scholar
• Gerdts V, Snider M, Brownlie R, Babiuk LA, Griebel PJ. Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate. J Immunol 2002; 168:1877-85; PMID:11823522; http://dx.doi.org/10.4049/jimmunol.168.4.1877
   PubMed Web of Science ®Google Scholar
• Levast B, Schulz S, Hurk S, Gerdts V. Animal models for neonatal diseases in humans. Vaccine 2013; 31:2489-99; PMID:23238328; http://dx.doi.org/10.1016/j.vaccine.2012.11.089
   PubMed Web of Science ®Google Scholar
• Pulendran B, Li S, Nakaya HI. Systems vaccinology. Immunity 2010; 33:516-29; PMID:21029962; http://dx.doi.org/10.1016/j.immuni.2010.10.006
   PubMed Web of Science ®Google Scholar
• Brookes RH, Hakimi J, Ha Y, Aboutorabian S, Ausar SF, Hasija M, Smith SG, Todryk SM, Dockrell HM, Rahman N. Screening vaccine formulations for biological activity using fresh human whole blood. Hum Vaccin Immunother 2014; 10:1129-35; PMID:24401565; http://dx.doi.org/10.4161/hv.27657
   PubMed Web of Science ®Google Scholar
• Aboutorabian S, Hakimi J, Boudet F, Montano S, Dookie A, Roque C, Ausar SF, Rahman N, Brookes RH. A high ratio of IC31 adjuvant to antigen is necessary for H4 TB vaccine immunomodulation. Hum Vaccin Immunother 2015; 11(6):1449-55; PMID:25997147
   PubMed Web of Science ®Google Scholar
• Bula CJ, Ghilardi G, Wietlisbach V, Petignat C, Francioli P. Infections and functional impairment in nursing home residents: a reciprocal relationship. J Am Geriatr Soc 2004; 52:700-6; PMID:15086648; http://dx.doi.org/10.1111/j.1532-5415.2004.52205.x
   PubMed Web of Science ®Google Scholar
• Vasto S, Colonna-Romano G, Larbi A, Wikby A, Caruso C, Pawelec G. Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun Ageing 2007; 4:2; PMID:17376222; http://dx.doi.org/10.1186/1742-4933-4-2
   PubMedGoogle Scholar
• Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A. Cytomegalovirus and human immunosenescence. Reviews Medical Virol 2009; 19:47-56; http://dx.doi.org/10.1002/rmv.598
   PubMed Web of Science ®Google Scholar
• Johnstone J, Parsons R, Botelho F, Millar J, McNeil S, Fulop T, McElhaney J, Andrew MK, Walter SD, Devereaux PJ, et al. Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents. PloS One 2014; 9:e108481; PMID:25275464; http://dx.doi.org/10.1371/journal.pone.0108481
   PubMedGoogle Scholar
• Ulloa-Montoya F, Louahed J, Dizier B, Gruselle O, Spiessens B, Lehmann FF, Suciu S, Kruit WH, Eggermont AM, Vansteenkiste J, et al. Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy. J Clin Oncol 2013; 31:2388-95; PMID:23715562; http://dx.doi.org/10.1200/JCO.2012.44.3762
   PubMed Web of Science ®Google Scholar
• Kruit WH, Suciu S, Dreno B, Mortier L, Robert C, Chiarion-Sileni V, Maio M, Testori A, Dorval T, Grob JJ, et al. Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma. J Clin Oncol 2013; 31:2413-20; PMID:23715572; http://dx.doi.org/10.1200/JCO.2012.43.7111
   PubMed Web of Science ®Google Scholar
• McGray AJ, Hallett R, Bernard D, Swift SL, Zhu Z, Teoderascu F, Vanseggelen H, Hassell JA, Hurwitz AA, Wan Y, et al. Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor. Mol Therapy 2014; 22:206-18; http://dx.doi.org/10.1038/mt.2013.255
   PubMed Web of Science ®Google Scholar
• McGray AJ, Bernard D, Hallett R, Kelly R, Jha M, Gregory C, Bassett JD, Hassell JA, Pare G, Wan Y, et al. Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients. Oncoimmunology 2012; 1:419-31; PMID:22754760; http://dx.doi.org/10.4161/onci.19534
   PubMed Web of Science ®Google Scholar